South Texas Money Management Ltd buys $28,944,254 stake in Varian Medical Systems (VAR)

Varian Medical Systems (VAR) : South Texas Money Management Ltd scooped up 7,597 additional shares in Varian Medical Systems during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 305,803 shares of Varian Medical Systems which is valued at $28,944,254.Varian Medical Systems makes up approximately 1.57% of South Texas Money Management Ltd’s portfolio.

Other Hedge Funds, Including , Anchor Capital Advisors reduced its stake in VAR by selling 14,634 shares or 2.45% in the most recent quarter. The Hedge Fund company now holds 583,737 shares of VAR which is valued at $55,250,707. Varian Medical Systems makes up approx 1.42% of Anchor Capital Advisors’s portfolio.Ownership Capital B.v. boosted its stake in VAR in the latest quarter, The investment management firm added 82,647 additional shares and now holds a total of 632,574 shares of Varian Medical Systems which is valued at $55,982,799. Varian Medical Systems makes up approx 8.51% of Ownership Capital B.v.’s portfolio.First National Bank Of Omaha reduced its stake in VAR by selling 47,003 shares or 93.13% in the most recent quarter. The Hedge Fund company now holds 3,470 shares of VAR which is valued at $302,272. Varian Medical Systems makes up approx 0.02% of First National Bank Of Omaha’s portfolio. Fox Run Management L.l.c. sold out all of its stake in VAR during the most recent quarter. The investment firm sold 3,600 shares of VAR which is valued $313,596.

Varian Medical Systems opened for trading at $94.63 and hit $95.21 on the upside on Thursday, eventually ending the session at $94.82, with a gain of 0.18% or 0.17 points. The heightened volatility saw the trading volume jump to 6,48,019 shares. Company has a market cap of $9,028 M.

On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.

Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Leave a Reply

Varian Medical Systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on Varian Medical Systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.